Exact Mass: 505.3013
Exact Mass Matches: 505.3013
Found 500 metabolites which its exact mass value is equals to given mass value 505.3013
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPE(0:0/20:2(11Z,14Z))
LysoPE(0:0/20:2(11Z,14Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:2(11Z,14Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(20:2(11Z,14Z)/0:0)
LysoPE(20:2(11Z,14Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:2(11Z,14Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Bardoxolone methyl
Capromorelin
Galactocerebroside
PC(17:2(9Z,12Z)/0:0)
6-(4-(2,2-Di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N'-di-2-propenyl-1,3,5-triazine-2,4-diamine
17-hydroxy-isomigrastatin|17-hydroxyisomigrastatin
Ile Phe Val Lys
Ala Phe Ile Arg
HMB-Val-Ser-Leu-VE
MLS001332642-01!Sodium glycocholate hydrate863-57-0
Ala Phe Leu Arg
Ala Phe Arg Ile
Ala Phe Arg Leu
Ala Ile Phe Arg
Ala Ile Arg Phe
Ala Leu Phe Arg
Ala Leu Arg Phe
Ala Pro Arg Tyr
Ala Pro Tyr Arg
Ala Arg Phe Ile
Ala Arg Phe Leu
Ala Arg Ile Phe
Ala Arg Leu Phe
Ala Arg Pro Tyr
Ala Arg Tyr Pro
Ala Tyr Pro Arg
Ala Tyr Arg Pro
Cys Lys Lys Lys
Cys Lys Lys Gln
Cys Lys Gln Lys
Cys Gln Lys Lys
Phe Ala Ile Arg
Phe Ala Leu Arg
Phe Ala Arg Ile
Phe Ala Arg Leu
Phe Ile Ala Arg
Phe Ile Ile Asn
Phe Ile Lys Val
Phe Ile Leu Asn
Phe Ile Asn Ile
Phe Ile Asn Leu
Phe Ile Gln Val
Phe Ile Arg Ala
Phe Ile Val Lys
Phe Ile Val Gln
Phe Lys Ile Val
Phe Lys Leu Val
Phe Lys Val Ile
Phe Lys Val Leu
Phe Leu Ala Arg
Phe Leu Ile Asn
Phe Leu Lys Val
Phe Leu Leu Asn
Phe Leu Asn Ile
Phe Leu Asn Leu
Phe Leu Gln Val
Phe Leu Arg Ala
Phe Leu Val Lys
Phe Leu Val Gln
Phe Asn Ile Ile
Phe Asn Ile Leu
Phe Asn Leu Ile
Phe Asn Leu Leu
Phe Pro Arg Ser
Phe Pro Ser Arg
Phe Gln Ile Val
Phe Gln Leu Val
Phe Gln Val Ile
Phe Gln Val Leu
Phe Arg Ala Ile
Phe Arg Ala Leu
Phe Arg Ile Ala
Phe Arg Leu Ala
Phe Arg Pro Ser
Phe Arg Ser Pro
Phe Ser Pro Arg
Phe Ser Arg Pro
Phe Val Ile Lys
Phe Val Ile Gln
Phe Val Lys Ile
Phe Val Lys Leu
Phe Val Leu Lys
Phe Val Leu Gln
Phe Val Gln Ile
Phe Val Gln Leu
His Pro Pro Arg
His Pro Arg Pro
His Arg Pro Pro
Ile Ala Phe Arg
Ile Ala Arg Phe
Ile Phe Ala Arg
Ile Phe Ile Asn
Ile Phe Lys Val
Ile Phe Leu Asn
Ile Phe Asn Ile
Ile Phe Asn Leu
Ile Phe Gln Val
Ile Phe Arg Ala
Ile Phe Val Gln
Ile Ile Phe Asn
Ile Ile Asn Phe
Ile Lys Phe Val
Ile Lys Val Phe
Ile Leu Phe Asn
Ile Leu Asn Phe
Ile Met Arg Ser
Ile Met Ser Arg
Ile Asn Phe Ile
Ile Asn Phe Leu
Ile Asn Ile Phe
Ile Asn Leu Phe
Ile Gln Phe Val
Ile Gln Val Phe
Ile Arg Ala Phe
Ile Arg Phe Ala
Ile Arg Met Ser
Ile Arg Ser Met
Ile Ser Met Arg
Ile Ser Arg Met
Ile Val Phe Lys
Ile Val Phe Gln
Ile Val Lys Phe
Ile Val Gln Phe
Lys Cys Lys Lys
Lys Cys Lys Gln
Lys Cys Gln Lys
Lys Phe Ile Val
Lys Phe Leu Val
Lys Phe Val Ile
Lys Phe Val Leu
Lys Ile Phe Val
Lys Ile Val Phe
Lys Lys Cys Lys
Lys Lys Cys Gln
Lys Lys Lys Cys
Lys Lys Gln Cys
Lys Leu Phe Val
Lys Leu Val Phe
Lys Pro Val Tyr
Lys Pro Tyr Val
Lys Gln Cys Lys
Lys Gln Lys Cys
Lys Val Phe Ile
Lys Val Phe Leu
Lys Val Ile Phe
Lys Val Leu Phe
Lys Val Pro Tyr
Lys Val Tyr Pro
Lys Tyr Pro Val
Lys Tyr Val Pro
Leu Ala Phe Arg
Leu Ala Arg Phe
Leu Phe Ala Arg
Leu Phe Ile Asn
Leu Phe Lys Val
Leu Phe Leu Asn
Leu Phe Asn Ile
Leu Phe Asn Leu
Leu Phe Gln Val
Leu Phe Arg Ala
Leu Phe Val Lys
Leu Phe Val Gln
Leu Ile Phe Asn
Leu Ile Asn Phe
Leu Lys Phe Val
Leu Lys Val Phe
Leu Leu Phe Asn
Leu Leu Asn Phe
Leu Met Arg Ser
Leu Met Ser Arg
Leu Asn Phe Ile
Leu Asn Phe Leu
Leu Asn Ile Phe
Leu Asn Leu Phe
Leu Gln Phe Val
Leu Gln Val Phe
Leu Arg Ala Phe
Leu Arg Phe Ala
Leu Arg Met Ser
Leu Arg Ser Met
Leu Ser Met Arg
Leu Ser Arg Met
Leu Val Phe Lys
Leu Val Phe Gln
Leu Val Lys Phe
Leu Val Gln Phe
Met Ile Arg Ser
Met Ile Ser Arg
Met Leu Arg Ser
Met Leu Ser Arg
Met Arg Ile Ser
Met Arg Leu Ser
Met Arg Ser Ile
Met Arg Ser Leu
Met Arg Thr Val
Met Arg Val Thr
Met Ser Ile Arg
Met Ser Leu Arg
Met Ser Arg Ile
Met Ser Arg Leu
Met Thr Arg Val
Met Thr Val Arg
Met Val Arg Thr
Met Val Thr Arg
Asn Phe Ile Ile
Asn Phe Ile Leu
Asn Phe Leu Ile
Asn Phe Leu Leu
Asn Ile Phe Ile
Asn Ile Phe Leu
Asn Ile Ile Phe
Asn Ile Leu Phe
Asn Leu Phe Ile
Asn Leu Phe Leu
Asn Leu Ile Phe
Asn Leu Leu Phe
Pro Ala Arg Tyr
Pro Ala Tyr Arg
Pro Phe Arg Ser
Pro Phe Ser Arg
Pro His Pro Arg
Pro His Arg Pro
Pro Lys Val Tyr
Pro Lys Tyr Val
Pro Pro His Arg
Pro Pro Arg His
Pro Arg Ala Tyr
Pro Arg Phe Ser
Pro Arg His Pro
Pro Arg Pro His
Pro Arg Ser Phe
Pro Arg Tyr Ala
Pro Ser Phe Arg
Pro Ser Arg Phe
Pro Val Lys Tyr
Pro Val Tyr Lys
Pro Tyr Ala Arg
Pro Tyr Lys Val
Pro Tyr Val Lys
Gln Cys Lys Lys
Gln Phe Ile Val
Gln Phe Leu Val
Gln Phe Val Ile
Gln Phe Val Leu
Gln Ile Phe Val
Gln Ile Val Phe
Gln Lys Cys Lys
Gln Lys Lys Cys
Gln Leu Phe Val
Gln Leu Val Phe
Gln Val Phe Ile
Gln Val Phe Leu
Gln Val Ile Phe
Gln Val Leu Phe
Arg Ala Phe Ile
Arg Ala Phe Leu
Arg Ala Ile Phe
Arg Ala Leu Phe
Arg Phe Ala Ile
Arg Phe Ala Leu
Arg Phe Ile Ala
Arg Phe Leu Ala
Arg His Pro Pro
Arg Ile Ala Phe
Arg Ile Phe Ala
Arg Ile Met Ser
Arg Ile Ser Met
Arg Leu Ala Phe
Arg Leu Phe Ala
Arg Leu Met Ser
Arg Leu Ser Met
Arg Met Ile Ser
Arg Met Leu Ser
Arg Met Ser Ile
Arg Met Ser Leu
Arg Met Thr Val
Arg Met Val Thr
Arg Pro His Pro
Arg Pro Pro His
Arg Ser Ile Met
Arg Ser Leu Met
Arg Ser Met Ile
Arg Ser Met Leu
Arg Thr Met Val
Arg Thr Val Met
Arg Val Met Thr
Arg Val Thr Met
Ser Ile Met Arg
Ser Ile Arg Met
Ser Leu Met Arg
Ser Leu Arg Met
Ser Met Ile Arg
Ser Met Leu Arg
Ser Met Arg Ile
Ser Met Arg Leu
Ser Arg Ile Met
Ser Arg Leu Met
Ser Arg Met Ile
Ser Arg Met Leu
Thr Met Arg Val
Thr Met Val Arg
Thr Arg Met Val
Thr Arg Val Met
Thr Val Met Arg
Thr Val Arg Met
Val Phe Ile Lys
Val Phe Ile Gln
Val Phe Lys Ile
Val Phe Lys Leu
Val Phe Leu Lys
Val Phe Leu Gln
Val Phe Gln Ile
Val Phe Gln Leu
Val Ile Phe Lys
Val Ile Phe Gln
Val Ile Lys Phe
Val Ile Gln Phe
Val Lys Phe Ile
Val Lys Phe Leu
Val Lys Ile Phe
Val Lys Leu Phe
Val Lys Pro Tyr
Val Lys Tyr Pro
Val Leu Phe Lys
Val Leu Phe Gln
Val Leu Lys Phe
Val Leu Gln Phe
Val Met Arg Thr
Val Met Thr Arg
Val Pro Lys Tyr
Val Pro Tyr Lys
Val Gln Phe Ile
Val Gln Phe Leu
Val Gln Ile Phe
Val Gln Leu Phe
Val Arg Met Thr
Val Arg Thr Met
Val Thr Met Arg
Val Thr Arg Met
Val Tyr Lys Pro
Val Tyr Pro Lys
Tyr Lys Pro Val
Tyr Lys Val Pro
Tyr Pro Lys Val
Tyr Pro Val Lys
Tyr Val Lys Pro
Tyr Val Pro Lys
ibha#20
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside that is icas#20 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
ibho#20
An omega-hydroxy fatty acid ascaroside that is bhos#20 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
(9-Butyl-9-fluorenyl)dicyclohexylphosphine tetrafluoroborate,cataCXium(R) FBu
1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-ium-1-yl]butan-1-one,chloride
3-(2-furyl)acryloyl-l-tryptophan dicyclohexylammonium salt
4-[2-[benzyl-[6-(4-phenylbutoxy)hexyl]amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol
Bardoxolone Methyl
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Capromorelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue
4-[6-[(8-Cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester
TAUROLITHOCHOLIC ACID SODIUM SALT
Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1].
Telapristone acetate
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
6-(4-(2,2-Di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N-di-2-propenyl-1,3,5-triazine-2,4-diamine
D000970 - Antineoplastic Agents
(3R)-12-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}-3-hydroxylauric acid
(3R,11R)-11-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}-3-hydroxylauric acid
[6-azaniumyl-1-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-4-hydroxy-6-(hydroxymethyl)-2-[(7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-3-ium-2-yl)amino]oxan-3-yl]amino]-1-oxohexan-3-yl]azanium
[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]carbamate
[3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(2S,3R)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(2S,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (11Z,14Z)-icosa-11,14-dienoate
[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] propanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] acetate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] butanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (5E,8E)-icosa-5,8-dienoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (11E,14E)-icosa-11,14-dienoate
2-[(11Z,14Z)-icosadienoyl]-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (11Z,14Z)-icosadienoyl.
1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphoethanolamine
streptothricin F(3+)
A primary aliphatic ammonium ion which is obtained from streptothricin F by protonation of the guanidino and amino groups.
1-[(9Z,12Z)-heptadecadienoyl]-sn-glycero-3-phosphocholine
A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (9Z,12Z)-heptadecadienoyl.
phosphatidylcholine 16:2
A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two phosphatidyl acyl groups contain a total of 16 carbons and 2 double bonds.
lysophosphatidylethanolamine 20:2
A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and 2 double bonds.
PE(20:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(19:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePE(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(16:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved